Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
Mehdi Farokhnia(National Institutes of Health), Shahin Akhondzadeh(Arak University of Medical Sciences), Maryam Kamalipour(Roozbeh Hospital), Negar Iranpour(Roozbeh Hospital), Habibeh Yekehtaz(Arak University of Medical Sciences), Farzaneh Farsad(Tehran University of Medical Sciences), Amirhossein Gougol(Tehran University of Medical Sciences), Mehdi Shafiee Sabet(Roozbeh Hospital), Roozbeh Alimardani(Tehran University of Medical Sciences)
Cited by 151
Related Papers
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
|JCI Insight|2023|200
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
|Pharmacological Reviews|2022|155
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
|Journal of Affective Disorders|2013|135
Education Attainment and Alcohol Binge Drinking: Diminished Returns of Hispanics in Los Angeles
|Behavioral Sciences|2019|131